News and Views


Nature Cell Biology 3, E43 - E46 (2001)
doi:10.1038/35055145

Death by design: the big debut of small molecules

Timothy S. Zheng1

  1. Timothy S. Zheng is at Biogen Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, USA.
    e-mail: timothy_zheng@biogen.com


Members of the Bcl-2 family are critical regulators of apoptosis and have become attractive targets for the development of anti-cancer drugs. The latest discovery of small-molecule inhibitors of Bcl-2 proteins may provide the sought-after leads for the development of new anti-cancer therapy

Top



Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Search PubMed for

Open Innovation Challenges

naturejobs